These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 19436756)

  • 1. Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy.
    Xilouri M; Vogiatzi T; Vekrellis K; Park D; Stefanis L
    PLoS One; 2009; 4(5):e5515. PubMed ID: 19436756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells.
    Vogiatzi T; Xilouri M; Vekrellis K; Stefanis L
    J Biol Chem; 2008 Aug; 283(35):23542-56. PubMed ID: 18566453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
    Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL
    Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson's disease pathogenesis.
    Xilouri M; Vogiatzi T; Vekrellis K; Stefanis L
    Autophagy; 2008 Oct; 4(7):917-9. PubMed ID: 18708765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity.
    Butler EK; Voigt A; Lutz AK; Toegel JP; Gerhardt E; Karsten P; Falkenburger B; Reinartz A; Winklhofer KF; Schulz JB
    PLoS Genet; 2012 Feb; 8(2):e1002488. PubMed ID: 22319455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of β-glucocerebrosidase activity does not affect alpha-synuclein levels or lysosomal function in neuronal cells.
    Dermentzaki G; Dimitriou E; Xilouri M; Michelakakis H; Stefanis L
    PLoS One; 2013; 8(4):e60674. PubMed ID: 23580063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy.
    Martinez-Vicente M; Talloczy Z; Kaushik S; Massey AC; Mazzulli J; Mosharov EV; Hodara R; Fredenburg R; Wu DC; Follenzi A; Dauer W; Przedborski S; Ischiropoulos H; Lansbury PT; Sulzer D; Cuervo AM
    J Clin Invest; 2008 Feb; 118(2):777-88. PubMed ID: 18172548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy.
    Choubey V; Safiulina D; Vaarmann A; Cagalinec M; Wareski P; Kuum M; Zharkovsky A; Kaasik A
    J Biol Chem; 2011 Mar; 286(12):10814-24. PubMed ID: 21252228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
    Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F
    J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of chaperone-mediated autophagy in neurotoxicity induced by alpha-synuclein after methamphetamine exposure.
    Sun L; Lian Y; Ding J; Meng Y; Li C; Chen L; Qiu P
    Brain Behav; 2019 Aug; 9(8):e01352. PubMed ID: 31286692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boosting chaperone-mediated autophagy in vivo mitigates α-synuclein-induced neurodegeneration.
    Xilouri M; Brekk OR; Landeck N; Pitychoutis PM; Papasilekas T; Papadopoulou-Daifoti Z; Kirik D; Stefanis L
    Brain; 2013 Jul; 136(Pt 7):2130-46. PubMed ID: 23757764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy mediates the clearance of oligodendroglial SNCA/alpha-synuclein and TPPP/p25A in multiple system atrophy models.
    Mavroeidi P; Arvanitaki F; Vetsi M; Becker S; Vlachakis D; Jensen PH; Stefanis L; Xilouri M
    Autophagy; 2022 Sep; 18(9):2104-2133. PubMed ID: 35000546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of trehalose on PC12 cells overexpressing wild-type or A53T mutant α-synuclein.
    Lan DM; Liu FT; Zhao J; Chen Y; Wu JJ; Ding ZT; Yue ZY; Ren HM; Jiang YP; Wang J
    Neurochem Res; 2012 Sep; 37(9):2025-32. PubMed ID: 22707286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro.
    Sala G; Bocci T; Borzì V; Parazzini M; Priori A; Ferrarese C
    Sci Rep; 2021 Jan; 11(1):2197. PubMed ID: 33500442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico modeling of the effects of alpha-synuclein oligomerization on dopaminergic neuronal homeostasis.
    Ouzounoglou E; Kalamatianos D; Emmanouilidou E; Xilouri M; Stefanis L; Vekrellis K; Manolakos ES
    BMC Syst Biol; 2014 May; 8():54. PubMed ID: 24885905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies.
    Xilouri M; Brekk OR; Stefanis L
    Mov Disord; 2016 Feb; 31(2):178-92. PubMed ID: 26813776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide Promotes the Clearance of α-Synuclein by Enhancing Autophagy in Neuronal Cells.
    Hu G; Gong X; Wang L; Liu M; Liu Y; Fu X; Wang W; Zhang T; Wang X
    Mol Neurobiol; 2017 Apr; 54(3):2361-2372. PubMed ID: 26957304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
    Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
    Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular aggregated alpha synuclein primarily triggers lysosomal dysfunction in neural cells prevented by trehalose.
    Hoffmann AC; Minakaki G; Menges S; Salvi R; Savitskiy S; Kazman A; Vicente Miranda H; Mielenz D; Klucken J; Winkler J; Xiang W
    Sci Rep; 2019 Jan; 9(1):544. PubMed ID: 30679445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease.
    Sala G; Marinig D; Riva C; Arosio A; Stefanoni G; Brighina L; Formenti M; Alberghina L; Colangelo AM; Ferrarese C
    Neurotoxicology; 2016 May; 54():161-169. PubMed ID: 27133439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.